EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

In Search of Spinal Muscular Atrophy Disease Modifiers

Daria Chudakova iD, Ludmila Kuzenkova, Andrey Fisenko, Kirill Savostyanov

International Journal of Molecular Sciences · 18.10.2024 · 25 (20) · 11210

DOI: 10.3390/ijms252011210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.10.2024. Verfasst von Daria Chudakova und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center of Children's Health of the Ministry of Health of the Russian Federation, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Survival of Motor Neuron 1 Protein. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 5q Spinal Muscular Atrophy (SMA) is a hereditary autosomal recessive disease caused by defects in the survival motor neuron (SMN1) gene encoding survival motor neuron (SMN) protein. Currently, it is the leading cause of infantile mortality worldwide. SMA is a progressive neurodegenerative disease with “continuum of clinical severity”, which can be modulated by genetic and epigenetic factors known as disease modifiers (DMs). Individuals (even siblings) with the same defects in SMN1 gene might have strikingly different types of SMA, supposedly due to the impact of DMs. There are several therapeutic options for SMA, all of them focusing on the restoration of the SMN protein levels to normal. Determining DMs and the pathways in which they are involved might aid in enhancing existing curative approaches. Furthermore, DMs might become novel therapeutic targets or prognostic biomarkers of the disease. This narrative review provides a brief overview of the genetics and pathobiology of SMA, and its bona fide modifiers. We describe novel, emerging DMs, approaches and tools used to identify them, as well as their potential mechanisms of action and impact on disease severity. We also propose several disease-modifying molecular mechanisms which could provide a partial explanation of the staggering variability of SMA phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Atrophy, SpinalSurvival of Motor Neuron 1 ProteinHumansAnimalsEpigenesis, Genetic

Stichwörter der Autor:innen

SMN1SMN2disease modifiershereditary autosomal recessive diseaseneurodegenerationspinal muscular atrophy

Substanzen

Survival of Motor Neuron 1 ProteinSMN1 protein, human

Autor:innen und Institutionen

  • National Medical Research Center of Children's Health of the Ministry of Health of the Russian Federation, 119991 Moscow, Russia.

ORCID-Profile: Daria Chudakova

Zitieren

APA

Chudakova, D., Kuzenkova, L., Fisenko, A., & Savostyanov, K. (2024). In Search of Spinal Muscular Atrophy Disease Modifiers. International Journal of Molecular Sciences, 25(20), 11210. https://doi.org/10.3390/ijms252011210

Vancouver

Chudakova D, Kuzenkova L, Fisenko A, Savostyanov K. In Search of Spinal Muscular Atrophy Disease Modifiers. International Journal of Molecular Sciences. 2024;25(20):11210. doi:10.3390/ijms252011210

BibTeX
@article{Chudakova2024,
  author = {Chudakova, Daria and Kuzenkova, Ludmila and Fisenko, Andrey and Savostyanov, Kirill},
  title = {In Search of Spinal Muscular Atrophy Disease Modifiers},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {11210},
  doi = {10.3390/ijms252011210}
}
Kostenlos starten →